The Modi government plans to ramp up Covid-19 vaccinations to as many as five million a day in the coming weeks, a report in the Hindustan Times said which cited an official who is a part of the task force that oversees the vaccination programme. The sharp increase could be achieved in part by doubling the number of shots administered at every vaccination centre to 200. The faster rollout is likely to coincide with the start of the second phase of the programme that will target the elderly and those with preexisting conditions. Read more here
High vaccination targets can be pulled off, but it can't be done by the government alone, said an opinion piece in ThePrint written by Nitin Pai, the director of the Takshashila Institution. Apart from elections, no public service in the country has been administered fully by the government alone. The fast rollout of Aadhaar to more than a billion people was thanks to the use of private-sector capabilities. Covid-19 testing rates improved significantly only after the Centre allowed private labs to perform the tests. The vaccination programme is no different. The rollout needs a boost from the private sector, as the Confederation of Indian Industry (CII) and several industry leaders have pointed out in recent days, the opinion piece said. Read more here
As states like Maharashtra and Kerala witness a sharp rise in coronavirus
cases, the Delhi government has employed a series of measures to prevent a similar surge in the city, a report in ThePrint said. The administration in the national capital has been advised to stay vigilant and also use cluster-based genome sequence testing and surveillance strategy to ensure there is no fresh outbreak of cases, the report said citing sources in the Delhi government. Read more here
As many as 7,684 variants of the novel coronavirus have been identified in India by researchers, a report in Business Today said. Researchers at Hyderabad's Cellular and Molecular Biology (CCMB) highlighted the importance of keeping a close eye out for new strains and localised outbreaks. The research paper titled "SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants" said escape mutations in the novel coronavirus can allow it to evade the immune response and in turn lead to unfavourable implications for vaccines and severity of the disease. Read more here
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.